Skip to main content
TipRanks
Go Ultimate75% OFF

Veri Medtech Holdings (VRHI) Stock Statistics & Valuation Metrics

5 Followers

Total Valuation

Veri Medtech Holdings has a market cap or net worth of $35.28M. The enterprise value is $35.97T.

Market Cap
$35.28M
Enterprise Value
$35.97T

Share Statistics

Veri Medtech Holdings has 8,000,004 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
8,000,004
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Veri Medtech Holdings’s return on equity (ROE) is 0.99 and return on invested capital (ROIC) is 123.26%.

Return on Equity (ROE)
0.99
Return on Assets (ROA)
-12.63
Return on Invested Capital (ROIC)
123.26%
Return on Capital Employed (ROCE)
0.96
Revenue Per Employee
433.93K
Profits Per Employee
-93.42K
Employee Count
25
Asset Turnover
58.68
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Veri Medtech Holdings is -18.25. Veri Medtech Holdings’s PEG ratio is 0.33.

PE Ratio
-18.25
PS Ratio
4.24
PB Ratio
-11.18
Price to FCF
1278.72
Price to Operating Cash Flow
1278.77
PEG Ratio
0.33

Income Statement

In the last 12 months, Veri Medtech Holdings had revenue of 10.85M and earned -2.34M in profits. Earnings per share was -0.30.

Revenue
10.85M
Gross Profit
8.17M
Operating Income
-2.27M
Pretax Income
-2.34M
Net Income
-2.34M
EBITDA
-2.15M
Earnings Per Share (EPS)
-0.30

Cash Flow

In the last 12 months, operating cash flow was 27.59K and capital expenditures 0, giving a free cash flow of 27.59K billion.

Operating Cash Flow
27.59K
Free Cash Flow
27.59K
Free Cash Flow per Share
0.00

Dividends & Yields

Veri Medtech Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
0.08%
Earnings Yield
-5.48%

Stock Price Statistics

Beta
0.16
52-Week Price Change
3.76%
50-Day Moving Average
4.70
200-Day Moving Average
3.96
Relative Strength Index (RSI)
27.73
Average Volume (3m)
258

Financial Position

Veri Medtech Holdings as a current ratio of 0.05, with Debt / Equity ratio of -22.12%

Current Ratio
0.05
Quick Ratio
0.05
Debt to Market Cap
0.02
Net Debt to EBITDA
-0.22
Interest Coverage Ratio
-33.28

Taxes

In the past 12 months, Veri Medtech Holdings has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Veri Medtech Holdings EV to EBITDA ratio is -18.99, with an EV/FCF ratio of 1292.60.

EV to Sales
4.29
EV to EBITDA
-18.99
EV to Free Cash Flow
1292.60
EV to Operating Cash Flow
1292.65

Balance Sheet

Veri Medtech Holdings has $19.51K in cash and marketable securities with $402.30K in debt, giving a net cash position of -$382.80K billion.

Cash & Marketable Securities
$19.51K
Total Debt
$402.30K
Net Cash
-$382.80K
Net Cash Per Share
-$0.05
Tangible Book Value Per Share
-$0.39

Margins

Gross margin is 73.74%, with operating margin of -22.77%, and net profit margin of -23.25%.

Gross Margin
73.74%
Operating Margin
-22.77%
Pretax Margin
-23.25%
Net Profit Margin
-23.25%
EBITDA Margin
-22.57%
EBIT Margin
-22.77%

Analyst Forecast

The average price target for Veri Medtech Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-5.59%
EPS Growth Forecast
-70.88%